HSV-1 usually causes oral herpes, while HSV-2 primarily affects the genitals. Herpes often has no symptoms, so you may not ...

The FDA has approved pritelivir to treat mucocutaneous lesions caused by herpes simplex virus in immunocompromised adult ...

The FDA has approved pritelivir (Hovilpri) tablets for adults with weakened immune systems who have mucocutaneous lesions ...

The novel oral helicase-primase inhibitor offers a non-intravenous option for immunocompromised adults with mucocutaneous HSV refractory to standard antivirals.

The regulatory decision followed findings from PRIOH-1 Part C, an open-label, comparator-controlled Phase III superiority ...

Asahi Kasei Therapeutics, Inc., the global specialty pharmaceutical business of Tokyo-based Asahi Kasei, with U.S. and ...

Vaccines are one of the most important medical inventions of modern times that have saved and enhanced innumerable lives around the world. Despite the technological advances in vaccine design and ...

Please provide your email address to receive an email when new articles are posted on . Despite a decline in herpes simplex virus type 2 infections over the course of decades, researchers calculated ...

Dublin, March 11, 2025 (GLOBE NEWSWIRE) -- The "Herpes Simplex Virus Infections - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for ...

Serum YKL-40 levels in patients with cervical cancer are elevated compared to patients with cervical intraepithelial neoplasia and healthy controls No significant financial relationships to disclose.

A new meta-analysis of randomized trials and observational studies finds no clear benefit or harm from adjunctive ...